drugset / Trial / NCT00434122

Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

NCT00434122

Phase 2 Completed 85 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindPrevention

Summary

The main purpose of this clinical research study is to investigate if degarelix can synchronise the growth of the egg sacs in the ovaries and if degarelix has any effect on the lining of the womb.

Timeline

Start
2007-03
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Degarelix Other / unclassified 2.5 mg Subcutaneous

Indications